Our Recommendations
- WHO Guidelines on tuberculosis infection prevention and control, 2019 update (2019)
- Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income Countries (2017)
- Mejores prácticas para la atención de pacientes con tuberculosis (2017)
- Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice (2019)
- Tuberculose. Guide pratique à l’usage des médecins, infirmiers, techniciens de laboratoire et auxiliaires de santé (2022)
New Publications
- WHO consolidated guidelines on tuberculosis: module 4: treatment and care (2025)
- Operational handbook on tuberculosis: module 6: tuberculosis and co-morbidities, 3rd ed (2025)
- Operational handbook on tuberculosis: module 6: tuberculosis and comorbidities, 3rd ed (2025)
- WHO operational handbook on tuberculosis: module 6: tuberculosis and comorbidities, 2nd ed (2024)
- Diagnostics, medical devices & other health products catalog (GDF) (2022)
Filter
71
Featured
Recommendations
9
New Publications
8
Language
Document type
No document type
39
Guidelines
16
Manuals
8
Training Material
2
Strategic & Response Plan
2
Fact sheets
2
Studies & Reports
1
Situation Updates
1
Countries / Regions
Ukraine
2
Western and Central Europe
2
Eastern Europe
2
Brazil
2
Russia
2
India
2
Tajikistan
1
Colombia
1
Albania
1
Armenia
1
Global
1
Germany
1
Moldova
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
35
Countries
4
Pharmacy & Technologies
1
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
Management of Diabetes Mellitus-Tuberculosis
recommended
1st edition
This resource provides practical guidance for front line health workers responsible for the diagnosis, management and care of patients with these two diseases. Published in collaboration with the World Diabetes Foundation
The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens
Una Guída Esencial de Buenas Pràcticas
Séptima Edición 2019
Руководство по инвестициям Глобального фонда для стран Восточной Европы и Центральной Азии. В ходе разработки Руководства Глобальный фонд стремился учесть мнени...
Septìeme Édition 2019
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...
Best Practice for the Care of Patients with Tuberculosis: a Guide for Low-Income CountriesThe practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide.
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate...
Цей документ описує кроки, необхідні для визначення скоригованого інтервалу QT (QTc) в
ході моніторингу ЕКГ пацієнтів, які отримують препарати для лікування ХР ТБ, що...
Este documento presenta modelos de algoritmos que permiten investigar por métodos bacteriológicos a los pacientes para el diagnóstico de tuberculosis (TB), TB asociada al Virus de Inmunodeficiencia Humana (TB-HIV) y TB drogorresistente (TBDR).
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
Assurer des prestations optimales dans la chaîne de soins destinés aux patients tuberculeux
Deuxième édition - Juin 2018
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Презентация о туберкулезе и диабете
Guide pour les pays à faibles revenus.
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
Guía para países de bajos ingresos. 2 edición
